BioCentury | Feb 12, 2021
Product Development
Tau vaccine moving toward late-stage trials for Alzheimer’s
...T cell responses by excluding any T cell epitopes from tau and instead inducing a tau-independent...
...still coming.The semorinemab news was the first major blow the tau hypothesis, which maintains that tau...
...target intracellular and extracellular tau? AC Immune’s vaccine will test the former; its small molecule tau...
...still coming.The semorinemab news was the first major blow the tau hypothesis, which maintains that tau...
...target intracellular and extracellular tau? AC Immune’s vaccine will test the former; its small molecule tau...